Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.2.2
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Stock Units Activity
The summary of RSU activity is as follows (in thousands, except per share data):
Number of Units
Weighted-Average Grant Date Fair Value Per Share Aggregate Intrinsic Value (in thousands)
Balances—December 31, 2021
 10,032,871 $ 8.60  $ 73,240 
Granted 17,818,829 $ 5.57   
Vested (3,520,956) $ 7.68   
Forfeited (1,129,478) $ 6.83   
Balances—September 30, 2022
 23,201,266 $ 6.49  $ 100,461 
Summary of stock-based compensation expense
The following sets forth the total stock-based compensation expense for the Company’s stock options included in the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Research and development expenses $ 9,409  $ 6,103  $ 37,519  $ 14,041 
Selling, general and administrative expenses 3,634  1,516  14,386  5,377 
Total stock-based compensation expense $ 13,043  $ 7,619  $ 51,905  $ 19,418